Cargando…
CXCR3 Expression Is Associated with Advanced Tumor Stage and Grade Influencing Survival after Surgery of Localised Renal Cell Carcinoma
SIMPLE SUMMARY: Localized renal cell carcinoma is primarily treated surgically by resection. Some patients carry criteria for a high risk of tumour recurrence, for which postoperative immunotherapy is approved and currently used. The receptor CXCR3 differentiates anti-tumour T cells, which are known...
Autores principales: | Lindner, Andrea Katharina, Martowicz, Agnieszka, Untergasser, Gerold, Haybaeck, Johannes, Compérat, Eva, Kocher, Florian, Seeber, Andreas, Thurnher, Martin, Pichler, Renate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954014/ https://www.ncbi.nlm.nih.gov/pubmed/36831346 http://dx.doi.org/10.3390/cancers15041001 |
Ejemplares similares
-
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
por: Pichler, Renate, et al.
Publicado: (2023) -
Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
por: Kocher, Florian, et al.
Publicado: (2022) -
Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma
por: Lindner, Andrea Katharina, et al.
Publicado: (2022) -
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
por: Martowicz, Agnieszka, et al.
Publicado: (2012) -
Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro
por: Seeber, Andreas, et al.
Publicado: (2015)